Shares of Rallybio Corporation (RLYB) are gaining around 19 percent in Monday morning trading after the company announced an agreement to acquire Avenzo Therapeutics, Inc. through a merger transaction.
The company's shares are currently trading at $17.25 on the Nasdaq, up 19.28 percent. The stock opened at $16.80 and has climbed as high as $17.25 so far in today's session. Over the past year, it has traded in a range of $2.16 to $17.25.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.